메뉴 건너뛰기




Volumn 93, Issue 1, 1998, Pages 2-3

Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE;

EID: 0032428369     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)80001-4     Document Type: Editorial
Times cited : (17)

References (20)
  • 1
    • 0002862031 scopus 로고    scopus 로고
    • Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: A randomized, double-blind trial showing the importance of metronidazole resistance
    • S Veldhuyzen van Zanten RH Hunt A Cockeram Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: A randomized, double-blind trial showing the importance of metronidazole resistance Am J Gastroenterol 93 1998 5 10
    • (1998) Am J Gastroenterol , vol.93 , pp. 5-10
    • Veldhuyzen van Zanten, S1    Hunt, RH2    Cockeram, A3
  • 2
    • 0003176358 scopus 로고    scopus 로고
    • Effectiveness of H. pylori treatment regimens in clinical practice: A community-based outcomes study
    • M Fennerty D Lieberman N Magaret Gorge Consortium Effectiveness of H. pylori treatment regimens in clinical practice: A community-based outcomes study Gastroenterology 112 1997 A14 (abstract)
    • (1997) Gastroenterology , vol.112 , pp. A14
    • Fennerty, M1    Lieberman, D2    Magaret, N3    Consortium, Gorge4
  • 3
    • 0010397219 scopus 로고    scopus 로고
    • Triple therapy with lansoprazole, clarithromycin and amoxicillin is highly effective in the eradication of Helicobacter pylori infection
    • M Fennerty T Bianchi P Rose Triple therapy with lansoprazole, clarithromycin and amoxicillin is highly effective in the eradication of Helicobacter pylori infection Gastroenterology 112 1997 A116 (abstract)
    • (1997) Gastroenterology , vol.112 , pp. A116
    • Fennerty, M1    Bianchi, T2    Rose, P3
  • 4
    • 0029820444 scopus 로고    scopus 로고
    • Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori
    • L Laine R Estrada E Trujillo Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori Aliment Pharmacol Ther 10 1996 1029 1033
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 1029-1033
    • Laine, L1    Estrada, R2    Trujillo, E3
  • 5
    • 0002749652 scopus 로고    scopus 로고
    • Randomized comparison of ranitidine bismuth citrate (RBS)-based triple therapies for H. pylori (HP)
    • L Laine R Estrada E Trujillo Randomized comparison of ranitidine bismuth citrate (RBS)-based triple therapies for H. pylori (HP) Gastroenterology 112 1997 A192 (abstract)
    • (1997) Gastroenterology , vol.112 , pp. A192
    • Laine, L1    Estrada, R2    Trujillo, E3
  • 6
    • 0001064865 scopus 로고    scopus 로고
    • Metronidazole and clarithromycin resistance among H. pylori isolates from a large hospital in the United States
    • MS Osato R Reddy DY Graham Metronidazole and clarithromycin resistance among H. pylori isolates from a large hospital in the United States Gastroenterology 112 1997 A1057 (abstract)
    • (1997) Gastroenterology , vol.112 , pp. A1057
    • Osato, MS1    Reddy, R2    Graham, DY3
  • 7
    • 0001229082 scopus 로고    scopus 로고
    • In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials
    • AS Weissfeld DE Simmons PH Vance In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials Gastroenterology 110 1996 A295 (abstract)
    • (1996) Gastroenterology , vol.110 , pp. A295
    • Weissfeld, AS1    Simmons, DE2    Vance, PH3
  • 8
    • 0000211308 scopus 로고    scopus 로고
    • Metronidzaole resistance is high in Korea and Columbia and appears to be rapidly increasing in the U.S.
    • R Reddy M Osato O Gutierrez Metronidzaole resistance is high in Korea and Columbia and appears to be rapidly increasing in the U.S. Gastroenterology 110 1996 A238 (abstract)
    • (1996) Gastroenterology , vol.110 , pp. A238
    • Reddy, R1    Osato, M2    Gutierrez, O3
  • 9
    • 0030903560 scopus 로고    scopus 로고
    • Resistance of Helicobacter pylori to antibiotics
    • F Megraud Resistance of Helicobacter pylori to antibiotics Aliment Pharmacol Ther 11 1997 43 53 (suppl 1)
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 43-53
    • Megraud, F1
  • 10
    • 0029949471 scopus 로고    scopus 로고
    • Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance
    • DY Graham WA de Boer GNJ Tytgat Choosing the best anti- Helicobacter pylori therapy: Effect of antimicrobial resistance Am J Gastroenterol 91 1996 1072 1076
    • (1996) Am J Gastroenterol , vol.91 , pp. 1072-1076
    • Graham, DY1    de Boer, WA2    Tytgat, GNJ3
  • 11
    • 0030898355 scopus 로고    scopus 로고
    • Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori
    • MA Smith DI Edwards Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori J Antimicrob Chemother 39 1997 347 353
    • (1997) J Antimicrob Chemother , vol.39 , pp. 347-353
    • Smith, MA1    Edwards, DI2
  • 12
    • 0029981650 scopus 로고    scopus 로고
    • Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication of triple therapy
    • PD Midolo JR Lambert J Turnidge Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication of triple therapy J Gastroenterol Hepatol 11 1996 290 292
    • (1996) J Gastroenterol Hepatol , vol.11 , pp. 290-292
    • Midolo, PD1    Lambert, JR2    Turnidge, J3
  • 13
    • 0028217883 scopus 로고
    • Impact of metronidazole resistance on the eradication of Helicobacter pylori
    • LA Noach WL Langenberg MA Bertola Impact of metronidazole resistance on the eradication of Helicobacter pylori Scand J Infect Dis 26 1994 321 327
    • (1994) Scand J Infect Dis , vol.26 , pp. 321-327
    • Noach, LA1    Langenberg, WL2    Bertola, MA3
  • 14
    • 4243700865 scopus 로고    scopus 로고
    • Effect of omeprazole, clarithromycin and tinidazole on the eradication of Helicobacter pylori and healing of gastric ulcer
    • F Bazzoli RM Zagari S Fossi Effect of omeprazole, clarithromycin and tinidazole on the eradication of Helicobacter pylori and healing of gastric ulcer Gastroenterology 110 1996 A60 (abstract)
    • (1996) Gastroenterology , vol.110 , pp. A60
    • Bazzoli, F1    Zagari, RM2    Fossi, S3
  • 15
    • 0029849823 scopus 로고    scopus 로고
    • Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection
    • AW Harris DI Pryce SM Gabe Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection Aliment Pharmacol Ther 10 1996 1005 1008
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 1005-1008
    • Harris, AW1    Pryce, DI2    Gabe, SM3
  • 16
    • 0031050777 scopus 로고    scopus 로고
    • Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: Does in vitro metronidazole resistance have any clinical relevance?
    • F Lerang B Moum JB Haug Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: Does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 92 1997 248 253
    • (1997) Am J Gastroenterol , vol.92 , pp. 248-253
    • Lerang, F1    Moum, B2    Haug, JB3
  • 17
    • 0030972411 scopus 로고    scopus 로고
    • One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection; the significance of imidazole resistance
    • JC Thijs AA Van Zwet WJ Thijs One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection; the significance of imidazole resistance Aliment Pharmacol Ther 11 1997 305 309
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 305-309
    • Thijs, JC1    Van Zwet, AA2    Thijs, WJ3
  • 18
    • 0029091042 scopus 로고
    • Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori
    • P Moayyedi P Sahay DS Tompkins Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori Eur J Gastroenterol Hepatol 7 1995 835 840
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 835-840
    • Moayyedi, P1    Sahay, P2    Tompkins, DS3
  • 19
    • 0030853464 scopus 로고    scopus 로고
    • Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori
    • T Breuer JG Kim IE Gurer Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori Aliment Pharmacol Ther 11 1997 523 527
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 523-527
    • Breuer, T1    Kim, JG2    Gurer, IE3
  • 20
    • 0030044807 scopus 로고    scopus 로고
    • Cost-effectiveness of treatment regimens for the eradication of H. pylori in duodenal ulcer
    • N Vakil MB Fennerty Cost-effectiveness of treatment regimens for the eradication of H. pylori in duodenal ulcer Am J Gastroenterol 91 1996 239 245
    • (1996) Am J Gastroenterol , vol.91 , pp. 239-245
    • Vakil, N1    Fennerty, MB2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.